First, our sDNA test employs a single methylation marker for fecal detection of CRC while the multitarget stool-based DNA test [14] screens mutations in KRAS, assays for hypermethylated promoters of BMP3 and NDRG4, and measures amount of hemoglobin in stool. The gene discussed is KRAS; the disease is colorectal carcinoma.